Prevalence of Multi Drug Resistant (MDR) in Gram Negative Bacterial isolates from different clinical samples
Keywords:
Multi Drug resistant, Antimicrobial Drug Resistance, Gram negative bacteriaAbstract
Antibiotic resistance is a worldwide problem that can cross international boundaries and spread between continents very easily and speedily. World health readers have described antibiotic resistant organisms as “nightmare bacteria” that pose a “catastrophic threat” to people in every country in the world. The use of antibiotic is the single most important factor leading to antibiotic resistance around the world. Emergence of resistance to multiple antimicrobial agents in pathogenic bacteria has become a significant public health threat as there are fewer, or even sometimes no, effective antimicrobial agents available for infections caused by these bacteria. Gram-positive and Gram-negative bacteria are both affected by the emergence and rise of antimicrobial resistance. As this problem continues to grow, harmonized definitions with which to describe and classify bacteria that are resistant to multiple antimicrobial agents are needed, so that epidemiological surveillance data can be reliably collected and compared across healthcare settings and countries. Present study will help to know the prevalent drug resistant bacterial strain and their resistance pattern and also to detect the incidence of Multi drug resistant (MDR) in Gram negative bacterial isolates in tertiary care hospital. This Prospective study will be conducted in central laboratory, Department of Microbiology, Pacific Institute of Medical Sciences Udaipur. Total 371 gram negative bacterial isolates were obtained in two and half year study. Male patients 53% and female patient's 47%. most of the bacteria isolated from Urine specimen 157 followed by pus sample 73. MDR was reported in GNB about 61.18%, Klebsiella spp 120 was the most reported bacteria in our study followed by E. coli, 112.
Downloads
References
A.-P. Magiorakos1, A. Srinivasan et al Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance Clin Microbiol Infect 2012; 18: 268–281 10.1111/j.1469-0691.2011.03570.x.
Silpi basak , priyanka singh et al Multidrug Resistant and Extensively Drug ResistantBacteria: A Study J Pathog 2016;2016:4065603. doi: 10.1155/2016/4065603. Epub 2016 Jan 28
A. Sharma, “Antimicrobial resistance: no action today, no cure tomorrow,” Indian Journal of Medical Microbiology, vol. 29, no. 2, pp. 91–92, 2011.
M. L. Cohen, “Changing patterns of infectious disease,” Nature, vol. 406, no. 6797, pp. 762–767, 2000.
L. H. Rosenberger, T. Hranjec, A. D. Politano et al., “Effective cohorting and ‘superisolation’ in a single intensive care unit in response to an outbreak of diverse multi-drug-resistant organisms,” Surgical Infections, vol. 12, no. 5, pp. 345–350, 2011.
E. Morales, F. Cots, M. Sala et al., “Hospital costs of nosocomialmulti-drug resistant Pseudomonas aeruginosa acquisition,” BMC Health Services Research, vol. 12, no. 1, article 122, 2012.
B. Sasirekha et al PREVALENCE OF ESBL, AMPC Β- LACTAMASES AND MRSA AMONG UROPATHOGENS AND ITS ANTIBIOGRAM EXCLI Journal 2013;12:81-88 – ISSN 1611-2156
C. A. Arias and B. E. Murray, “Antibiotic-resistant bugs in the 21st century—a clinical super-challenge,” The New Englan Journal of Medicine, vol. 360, no. 5, pp. 439–443, 2009.
Ibrahim ME, Bilal NE Increased multi-drug resistant Escherichia coli from hospitals in Khartoum state, Sudan African Health Sciences 2012; 12(3): 368 - 375
Meng Wang1#, Hongyan Wei Analysis of multidrug-resistant bacteria in 3223 patients with hospital-acquired infections (HAI) from a tertiary general hospital in China Bosn J Basic Med Sci. 2019;19(1):86-93.
Trupti Bajpai, Ganesh S. et al Prevalence of multi, extensively and pan drug resistant uropathogens among the women patients visiting a tertiary care hospital in central India .International Journal of Health System and Disaster Management | Vol. 2 | Issue 1 |10.4103/2347-9019.135357.
CLSI Guidelines for Antimicrobial resistance - 2022. CLSI USA 20th ED. 2022.
Apurba Shastri: Essential of Practical Microbiology: 2nd Edition 2023, JP Publisher India.
HiMedia Antimicrobial Disc Catalogue MD-28 for Susceptibility testing 2022.
A Srinivasan et al. 2012. MDR and XDR bacteria - an international expert proposal for interm standard definition for acquired resistance. Vol. 18 Issue 3, Pg 268-81: 2012.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.